Materiały źródłowe

• #1 Parkinson’s disease – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/parkinsons-disease/diagnosis-treatment/drc-20376062

  Currently, there isn’t a specific test to diagnose Parkinson’s disease. A diagnosis is made by a doctor trained in nervous system conditions, known as a neurologist. A diagnosis of Parkinson’s is based on your medical history, a review of your symptoms, and a neurological and physical exam. […] It can take time to diagnose Parkinson’s disease. Healthcare professionals may recommend regular follow-up appointments with neurologists trained in movement disorders to evaluate your condition and symptoms over time and diagnose Parkinson’s disease. […] Your healthcare team may order some of these tests and procedures: […] A specific single-photon emission computerized tomography (SPECT) scan called a dopamine transporter (DAT) scan. This can help support the suspicion that you have Parkinson’s disease and help identify different types of tremor. But it is your symptoms and the results of your neurological exam that determine your diagnosis. Most people do not require a DAT scan.

• #2 Diagnosing Parkinson’s Disease | APDA

  https://www.apdaparkinson.org/what-is-parkinsons/diagnosing/

  The diagnosis of Parkinsons disease (PD) can be relatively straightforward by detecting particular clinical features, such as rest tremor, stiffness, and slowness on neurological exam. Typically, detecting these features leads to an accurate diagnosis, without any further testing needed. […] In cases where the diagnosis remains uncertain, an imaging test called a DaTscan is available. However, this approach to PD diagnosis is rapidly evolving. Advances in the development of biomarkers is starting to change how PD is diagnosed and will potentially allow for diagnosis at an earlier stage than is possible now. […] Typically, a trained physician will only consider the diagnosis of Parkinsons disease if the person being examined has at least two of the core motor symptoms of Parkinsons, including tremor, the characteristic bradykinesia (slowness of movement), or rigidity. At the end of your visit, the physician should discuss with you why you may or may not have Parkinsons disease and the level of certainty about the diagnosis. This determination is based on your medical history and examination at this visit.

• #3 Getting Diagnosed | Parkinson’s Foundation

  https://www.parkinson.org/understanding-parkinsons/getting-diagnosed

  Finding out you have Parkinson’s can be a lengthy process. Explore how a Parkinson’s diagnosis is made and what type of diagnostic tools are used. […] Parkinsons disease (PD) is a clinical diagnosis. This means that an individuals history, symptoms, and physical exam are used to make the diagnosis. There is not a specific lab or imaging test that can diagnose PD. However, certain tests such as magnetic resonance imaging of the brain (MRI brain), a dopamine transporter scan (DaT scan), or blood work can be used to support the diagnosis of PD or to rule out other medical conditions that can mimic PD. […] Making an accurate diagnosis of Parkinsons, particularly in its early stages, can be difficult. Often, an internist or family physician is the first to make a diagnosis. Many people may seek an additional opinion from a movement disorder specialist. A movement disorder specialist is a neurologist with experience and specific training in the assessment and treatment of PD and related disorders.

• #4 Getting Diagnosed | Parkinson’s Foundation

  https://www.parkinson.org/understanding-parkinsons/getting-diagnosed

  The newest criteria for diagnosing Parkinsons was developed by the International Parkinson and Movement Disorder Society (MDS), and reflect the most current understanding of PD. […] To consider a diagnosis of Parkinsons disease, a person must have bradykinesia (slowness of movement). In addition to bradykinesia, a person must also have one or more of the following: Shaking or tremor in a limb that occurs while it is at rest, Stiffness or rigidity of the arms, legs, or trunk, Trouble with balance and falls. […] The first and most important diagnostic tool for Parkinsons is a medical history and physical examination conducted by a neurologist. […] A neurologist will make a diagnosis based on: A detailed history of symptoms, existing medical conditions, current and past medications, family history, and lifestyle factors. Certain medical conditions, as well as some medications, can cause symptoms similar to Parkinsons.

• #5 Update on the diagnosis and management of Parkinson’s disease

  https://pmc.ncbi.nlm.nih.gov/articles/PMC7385761/

  Parkinson’s disease (PD) is diagnosed where bradykinesia occurs together with rigidity or tremor, in the presence of supporting features. The diagnosis is clinical, and attention should be paid to exclusion criteria indicating an alternative diagnosis and to red flag features. […] The diagnosis of PD is clinical and requires bradykinesia, defined as slowness of movement and decrement in amplitude or speed, usually assessed using finger tapping, foot tapping or pronationsupination hand movements. In addition, rest tremor or rigidity is required to confirm a parkinsonian syndrome. […] Post-mortem studies of clinically diagnosed PD show an overall diagnostic accuracy of 81%, indicating the need to re-appraise the clinical diagnosis regularly. […] The most common causes of PD misdiagnosis are atypical parkinsonian syndromes, including multiple system atrophy (MSA) and progressive supranuclear palsy (PSP). […] The diagnosis of PD remains clinical, and close attention and review for features indicating an alternative diagnosis is key given the absence of a definitive diagnostic test.

• #6

  https://www.movementdisorders.org/MDS/News/Newsroom/Position-Papers/MDS-Position-Diagnosis-of-PD.htm

  The Scientific Issues Committee on behalf of the International Parkinson and Movement Disorder Society (MDS) is providing this statement regarding the diagnosis of Parkinsons disease (PD). This statement is based on the current best available evidence. […] The MDS supports their use as a general guide to diagnosis of PD in clinical settings, and the criteria currently represent the global standard for PD diagnosis. […] The prerequisite to apply the MDS-PD criteria is the diagnosis of parkinsonism, which is based on three clinical motor features (bradykinesia, rest tremor, rigidity). […] Therefore, diagnosis of PD requires sufficient training in neurology. […] However, there is no reliable scientific evidence to support the use of blood tests or EEG as diagnostic tests for PD and therefore they are not included in the MDS-PD criteria.

• #7 Update on the diagnosis and management of Parkinson’s disease

  https://pmc.ncbi.nlm.nih.gov/articles/PMC7385761/

  Parkinson’s disease (PD) is diagnosed where bradykinesia occurs together with rigidity or tremor, in the presence of supporting features. The diagnosis is clinical, and attention should be paid to exclusion criteria indicating an alternative diagnosis and to red flag features. […] The diagnosis of PD is clinical and requires bradykinesia, defined as slowness of movement and decrement in amplitude or speed, usually assessed using finger tapping, foot tapping or pronationsupination hand movements. In addition, rest tremor or rigidity is required to confirm a parkinsonian syndrome. […] Post-mortem studies of clinically diagnosed PD show an overall diagnostic accuracy of 81%, indicating the need to re-appraise the clinical diagnosis regularly. […] The most common causes of PD misdiagnosis are atypical parkinsonian syndromes, including multiple system atrophy (MSA) and progressive supranuclear palsy (PSP). […] The diagnosis of PD remains clinical, and close attention and review for features indicating an alternative diagnosis is key given the absence of a definitive diagnostic test.

• #8 Getting Diagnosed | Parkinson’s Foundation

  https://www.parkinson.org/understanding-parkinsons/getting-diagnosed

  The newest criteria for diagnosing Parkinsons was developed by the International Parkinson and Movement Disorder Society (MDS), and reflect the most current understanding of PD. […] To consider a diagnosis of Parkinsons disease, a person must have bradykinesia (slowness of movement). In addition to bradykinesia, a person must also have one or more of the following: Shaking or tremor in a limb that occurs while it is at rest, Stiffness or rigidity of the arms, legs, or trunk, Trouble with balance and falls. […] The first and most important diagnostic tool for Parkinsons is a medical history and physical examination conducted by a neurologist. […] A neurologist will make a diagnosis based on: A detailed history of symptoms, existing medical conditions, current and past medications, family history, and lifestyle factors. Certain medical conditions, as well as some medications, can cause symptoms similar to Parkinsons.

• #9 Parkinson’s Disease Exam | Stanford Medicine 25 | Stanford Medicine

  https://stanfordmedicine25.stanford.edu/the25/parkinsondisease.html

  Parkinsons Disease is one of the most commonly diagnosed motor disorders. It is important to be familiar with the physical exam so that you can confirm the diagnosis and monitor how the treatment is benefiting the patient over time. […] The physical exam in Parkinsons disease (PD) is essential both for making a diagnosis and following the patient over time. It consists of a series of tests and maneuvers that help us identify and evaluate the four main characteristics of the disease: […] In order to make a diagnosis, we must observe bradykinesia plus either one of the other motor abnormalities. Once a diagnosis is made and the patient is started on treatment, it is important to check these four features at every follow up visit, so that we can gauge the treatment based on how the exam has changed over time.

• #10 Parkinson’s Disease Exam | Stanford Medicine 25 | Stanford Medicine

  https://stanfordmedicine25.stanford.edu/the25/parkinsondisease.html

  It is important to remember that the inspection starts as soon as the patient walks in to the room. […] Bradykinesia is defined as a generalized slowness of movement, with patients struggling in particular with starting a movement. It is seen in almost every patient with Parkinsons disease, making its presence essential for diagnosis. […] To test for the presence of bradykinesia we will have the patient perform rapid alternating movements. […] In finger tapping the patient is instructed to tap the index finger on the thumb as fast possible and as big as possible. […] If the patient has arthritis of the hand joints, the finger tapping is not a very sensitive test. In this case, we can use other tests such as the fist open close. […] To test for the presence of rigidity, we need to passively manipulate the limbs of the patient.

• #11 Parkinson’s Disease Exam | Stanford Medicine 25 | Stanford Medicine

  https://stanfordmedicine25.stanford.edu/the25/parkinsondisease.html

  It is important to remember that the inspection starts as soon as the patient walks in to the room. […] Bradykinesia is defined as a generalized slowness of movement, with patients struggling in particular with starting a movement. It is seen in almost every patient with Parkinsons disease, making its presence essential for diagnosis. […] To test for the presence of bradykinesia we will have the patient perform rapid alternating movements. […] In finger tapping the patient is instructed to tap the index finger on the thumb as fast possible and as big as possible. […] If the patient has arthritis of the hand joints, the finger tapping is not a very sensitive test. In this case, we can use other tests such as the fist open close. […] To test for the presence of rigidity, we need to passively manipulate the limbs of the patient.

• #12 The initial diagnosis and management of Parkinson’s disease

  https://www1.racgp.org.au/ajgp/2021/november/diagnosis-and-management-of-parkinsons

  Patients may present with somatic complaints, such as constipation, or orthopaedic problems including shoulder pain. […] Such patients are often first referred to a rheumatologist, orthopaedic surgeon or psychiatrist before the diagnosis of Parkinsons disease is suspected. […] Parkinsons disease remains a clinical diagnosis, and a careful history and examination are critical in recognising the diagnosis. […] Knowledge of these symptoms may facilitate early diagnosis and aid effective treatment by recognising the impact of non-motor manifestations on disability and quality of life. […] Limb bradykinesia is required for the diagnosis, but particularly movement that reduces in amplitude with repetition, termed motor decrement. […] The rest tremor of Parkinsons disease is typically slow (46 Hz), most commonly in the distal upper limb and asymmetrical, although lower limb onset can occur.

• #13 Parkinson’s Disease Exam | Stanford Medicine 25 | Stanford Medicine

  https://stanfordmedicine25.stanford.edu/the25/parkinsondisease.html

  Rigidity is defined as increased resistance to passive movement about a joint. […] To test for the presence of rigidity in the lower extremity, place your top hand under the patients knee to fully support the weight of the leg and make sure the extremity is relaxed. […] Tremor is defined as an involuntary trembling of a body part. […] All of these types of tremor can be seen in Parkinsons disease, even though resting tremor is the more frequently observed one and also the most severe when all three tremors are present in PD. […] To test for postural tremor, first have the patient fully extend the elbow and flex the arm forward at 90. […] Patients with Parkinsons disease can develop an alteration of the postural reflexes that causes instability in gait and balance control. […] Using the exam to pick up postural instability is of the utmost importance for the management of patients with PD, since it will trigger either a medication adjustment or a physical therapy intervention both aimed at falls prevention.

• #14 Parkinson’s Disease Exam | Stanford Medicine 25 | Stanford Medicine

  https://stanfordmedicine25.stanford.edu/the25/parkinsondisease.html

  Rigidity is defined as increased resistance to passive movement about a joint. […] To test for the presence of rigidity in the lower extremity, place your top hand under the patients knee to fully support the weight of the leg and make sure the extremity is relaxed. […] Tremor is defined as an involuntary trembling of a body part. […] All of these types of tremor can be seen in Parkinsons disease, even though resting tremor is the more frequently observed one and also the most severe when all three tremors are present in PD. […] To test for postural tremor, first have the patient fully extend the elbow and flex the arm forward at 90. […] Patients with Parkinsons disease can develop an alteration of the postural reflexes that causes instability in gait and balance control. […] Using the exam to pick up postural instability is of the utmost importance for the management of patients with PD, since it will trigger either a medication adjustment or a physical therapy intervention both aimed at falls prevention.

• #15 Getting Diagnosed | Parkinson’s Foundation

  https://www.parkinson.org/understanding-parkinsons/getting-diagnosed

  You may notice that a neurologist records your exam according to the Unified Parkinsons Disease Rating Scale (UPDRS). This is a universal scale used by neurologists and movement disorder specialists to comprehensively assess and document the exam of a person with PD. […] Lack of response to medications may prompt the doctor to seek an alternative diagnosis and order further testing such as an MRI of the brain or lab work. When unsure of a PD diagnosis, a DaTscan can also be considered but is not needed in all cases. […] A DaTscan is an imaging technology that allows visualization of the dopamine system in the brain. It is similar to an MRI, but instead of looking at the structure of the brain it looks at the function. A DaTscan can show if there is reduced function of the dopamine system in an area of the brain involved in controlling movement.

• #16 Parkinson’s disease – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/parkinsons-disease/diagnosis-treatment/drc-20376062

  Currently, there isn’t a specific test to diagnose Parkinson’s disease. A diagnosis is made by a doctor trained in nervous system conditions, known as a neurologist. A diagnosis of Parkinson’s is based on your medical history, a review of your symptoms, and a neurological and physical exam. […] It can take time to diagnose Parkinson’s disease. Healthcare professionals may recommend regular follow-up appointments with neurologists trained in movement disorders to evaluate your condition and symptoms over time and diagnose Parkinson’s disease. […] Your healthcare team may order some of these tests and procedures: […] A specific single-photon emission computerized tomography (SPECT) scan called a dopamine transporter (DAT) scan. This can help support the suspicion that you have Parkinson’s disease and help identify different types of tremor. But it is your symptoms and the results of your neurological exam that determine your diagnosis. Most people do not require a DAT scan.

• #17 Getting Diagnosed | Parkinson’s Foundation

  https://www.parkinson.org/understanding-parkinsons/getting-diagnosed

  Finding out you have Parkinson’s can be a lengthy process. Explore how a Parkinson’s diagnosis is made and what type of diagnostic tools are used. […] Parkinsons disease (PD) is a clinical diagnosis. This means that an individuals history, symptoms, and physical exam are used to make the diagnosis. There is not a specific lab or imaging test that can diagnose PD. However, certain tests such as magnetic resonance imaging of the brain (MRI brain), a dopamine transporter scan (DaT scan), or blood work can be used to support the diagnosis of PD or to rule out other medical conditions that can mimic PD. […] Making an accurate diagnosis of Parkinsons, particularly in its early stages, can be difficult. Often, an internist or family physician is the first to make a diagnosis. Many people may seek an additional opinion from a movement disorder specialist. A movement disorder specialist is a neurologist with experience and specific training in the assessment and treatment of PD and related disorders.

• #18 Parkinson’s Disease: What It Is, Causes, Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/8525-parkinsons-disease-an-overview

  Diagnosing Parkinsons disease is mostly a clinical process, meaning it relies heavily on a healthcare provider examining your symptoms, asking questions and reviewing your medical history. Some diagnostic and lab tests are possible, but these are usually needed to rule out other conditions or certain causes. […] When healthcare providers suspect Parkinsons disease or need to rule out other conditions, various imaging and diagnostic tests are possible. These include: Blood tests (these can help rule out other forms of parkinsonism). Computed tomography (CT) scan. Genetic testing. Magnetic resonance imaging (MRI). Positron emission tomography (PET) scan. […] Researchers have found possible ways to test for possible indicators of Parkinsons disease. Both of these new tests involve the alpha-synuclein protein but test for it in new, unusual ways. While these tests cant tell you what conditions you have because of misfolded alpha-synuclein proteins, that information can still help your provider make a diagnosis.

• #19 Parkinson Disease Workup: Approach Considerations, Radiologic Studies, Histologic Findings

  https://emedicine.medscape.com/article/1831191-workup

  MRI should be obtained in patients whose clinical presentation does not allow a high degree of diagnostic certainty, including those who lack tremor, have an acute or stepwise progression, or are younger than 55 years. […] Positron emission tomography (PET) and single-photon emission computed tomography (SPECT) scanning are useful diagnostic imaging studies, but these are not routinely required. […] Deficits on 123I SPECT scans indicate a dopamine deficiency syndrome but do not differentiate Parkinson disease from atypical parkinsonisms, including multiple system atrophy (MSA) and progressive supranuclear palsy (PSP). […] Classic pathologic findings in Parkinson disease include degeneration of the neurons containing neuromelanin, especially in the substantia nigra and the locus ceruleus.

• #20 Parkinson’s Disease: What It Is, Causes, Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/8525-parkinsons-disease-an-overview

  Diagnosing Parkinsons disease is mostly a clinical process, meaning it relies heavily on a healthcare provider examining your symptoms, asking questions and reviewing your medical history. Some diagnostic and lab tests are possible, but these are usually needed to rule out other conditions or certain causes. […] When healthcare providers suspect Parkinsons disease or need to rule out other conditions, various imaging and diagnostic tests are possible. These include: Blood tests (these can help rule out other forms of parkinsonism). Computed tomography (CT) scan. Genetic testing. Magnetic resonance imaging (MRI). Positron emission tomography (PET) scan. […] Researchers have found possible ways to test for possible indicators of Parkinsons disease. Both of these new tests involve the alpha-synuclein protein but test for it in new, unusual ways. While these tests cant tell you what conditions you have because of misfolded alpha-synuclein proteins, that information can still help your provider make a diagnosis.

• #21 Parkinson’s disease – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/parkinsons-disease/diagnosis-treatment/drc-20376062

  Currently, there isn’t a specific test to diagnose Parkinson’s disease. A diagnosis is made by a doctor trained in nervous system conditions, known as a neurologist. A diagnosis of Parkinson’s is based on your medical history, a review of your symptoms, and a neurological and physical exam. […] It can take time to diagnose Parkinson’s disease. Healthcare professionals may recommend regular follow-up appointments with neurologists trained in movement disorders to evaluate your condition and symptoms over time and diagnose Parkinson’s disease. […] Your healthcare team may order some of these tests and procedures: […] A specific single-photon emission computerized tomography (SPECT) scan called a dopamine transporter (DAT) scan. This can help support the suspicion that you have Parkinson’s disease and help identify different types of tremor. But it is your symptoms and the results of your neurological exam that determine your diagnosis. Most people do not require a DAT scan.

• #22 Diagnosing Parkinson’s Disease | APDA

  https://www.apdaparkinson.org/what-is-parkinsons/diagnosing/

  DaTscan is an imaging test which helps to visualize the dopamine system in the brain. It is most helpful when the diagnosis is uncertain, or your physician is trying to distinguish PD from certain other conditions that can mimic Parkinsons. […] There are two new tests for Parkinsons disease that are commercially available. One is a test on the cerebral spinal fluid and the other requires a set of skin biopsies. Both of these tests are currently available but undergoing further evaluation to determine how best to utilize them in clinical practice. Your doctor will decide whether these tests are necessary to help in your diagnosis. […] If a persons symptoms and neurologic examination are only suggestive of Parkinsons disease or if the diagnosis is otherwise in doubt, the physician may prescribe a medication intended for Parkinsons disease in order to gauge the response. In the case of typical Parkinsons disease, there is a positive, predictable response to Parkinsons disease medication; in the case of some related Parkinsonian syndromes, the response to medication may not be particularly robust, or it may be absent entirely.

• #23 5. Diagnosis of Parkinson’s Disease | ATrain Education

  https://www.atrainceu.com/content/5-diagnosis-parkinson%E2%80%99s-disease

  Functional imaging techniques such as positron emission tomography (PET) or single photon computed emission tomography (SPECT) using radioactively labeled ligands of the presynaptic dopaminergic neurons can support the diagnosis but are usually limited to a research setting. […] A specific technique of MRI, diffusion MRI, has been reported to be useful at discriminating between typical and atypical parkinsonism, although its exact diagnostic value is still under investigation. […] Generally a pattern of reduced dopaminergic activity in the basal ganglia can aid in diagnosing PD.

• #24 Getting Diagnosed | Parkinson’s Foundation

  https://www.parkinson.org/understanding-parkinsons/getting-diagnosed

  A negative DaTscan suggests that a person does not have Parkinsons. It is important to know that a negative DaTscan does not rule out PD, especially early in the disease, but a positive DaTscan can help confirm it. […] The Syn-One Test is a pathological test that uses a skin sample to confirm the presence of phosphorylation in nerves, which can carry the protein that plays an essential role in Parkinsons. Test results can help PD doctors confirm a Parkinsons diagnosis. […] The test only confirms an abnormality is present, and cannot distinguish between Parkinsons disease, dementia with Lewy bodies, multiple system atrophy or REM sleep behavior disorder. A doctor uses the test results alongside other tests to confirm a Parkinsons diagnosis. […] Parkinsons disease is diagnosed using the combination of a neurological examination, response to dopamine therapies and multiple follow-up visits. The Syn-One Test alone does not diagnose Parkinsons.

• #25 Parkinson’s, Movement Disorders Diagnosis | Froedtert & MCW

  https://www.froedtert.com/parkinsons-movement-disorders/diagnostics

  Diagnosis of Parkinson’s disease and other movement disorders is based primarily on a medical history and thorough physical and neurological examination. If necessary, additional tests or imaging may be requested for the patient, taking advantage of the latest diagnostic tools available at Froedtert the Medical College of Wisconsin. Brain scans like the DaTSCAN and/or lab tests may be performed to help rule out other diseases or conditions. […] This new, highly specialized brain scan aid offers physicians for the first time the ability to definitively determine whether or not a patients symptoms are related to Parkinsons disease or related syndromes. The earlier an accurate diagnosis of a movement disorder can be made, the sooner effective treatment can begin. […] DaTSCAN is an FDA-approved substance used to detect the presence of dopamine transporters (DaT) in the brain, which would be low in patients with Parkinsons disease or a parkinsonian syndrome. For the procedure, a patient receives an injection of the substance and then, a few hours later, undergoes a single-photon emission computed tomography (SPECT) scan that will show change in the brains chemistry. The test is painless and results are quickly available.

• #26 How is Parkinson’s diagnosed? | Parkinson’s UK

  https://www.parkinsons.org.uk/information-and-support/how-parkinsons-diagnosed

  Research suggests that Parkinsons tends to develop gradually. […] This information looks at how Parkinsons may be diagnosed, and explains some of the tests that may be involved in the process. […] If your GP suspects you have Parkinsons, clinical guidelines recommend they should refer you quickly to a specialist with experience in diagnosing the condition. […] Its not always easy to diagnose Parkinsons. Theres currently no single or definitive test that can diagnose the condition and there are other conditions that have similar symptoms. […] Your specialist will take a detailed medical history and examine you. […] After examining you, and depending on how much your symptoms affect you, your specialist may suggest you start taking medication for Parkinsons. […] If your symptoms improve after taking Parkinsons medication for a few weeks or months, your specialist may confirm Parkinsons diagnosis.

• #27 Parkinson Disease – Neurologic Disorders – Merck Manual Professional Edition

  https://www.merckmanuals.com/professional/neurologic-disorders/movement-and-cerebellar-disorders/parkinson-disease

  Parkinson disease is a slowly progressive, degenerative disorder characterized by resting tremor, stiffness (rigidity), slow and decreased movement (bradykinesia), and eventually gait and/or postural instability. Diagnosis is clinical. […] Diagnosis of Parkinson disease is clinical. Parkinson disease is suspected in patients with characteristic unilateral resting tremor, decreased movement, or rigidity. […] The diagnosis of Parkinson disease is supported by the presence of other signs such as infrequent blinking, lack of facial expression, and gait abnormalities. […] To help distinguish Parkinson disease from secondary or atypical parkinsonism, clinicians often test responsiveness to levodopa. A large, sustained response strongly supports Parkinson disease. […] Dopamine ligand imaging can help distinguish between Parkinson disease (abnormal imaging findings) and drug-induced parkinsonism (normal imaging findings) or essential tremor (normal imaging findings). However, this imaging cannot discriminate between different types of degenerative parkinsonism such as Parkinson disease and dementia with Lewy bodies.

• #28 Diagnosis and differential diagnosis of Parkinson disease – UpToDate

  https://www.uptodate.com/contents/diagnosis-and-differential-diagnosis-of-parkinson-disease

  Diagnosis and differential diagnosis of Parkinson disease […] Because no diagnostic tests have been developed to distinguish PD from other forms of parkinsonism in vivo, PD remains a clinical diagnosis, based on the clinician’s ability to recognize its characteristic signs and associated symptoms, especially in the early stages. An accurate clinical diagnosis is fundamental to the expectation that pharmacotherapy of PD will be effective. In general, the other forms of parkinsonism respond poorly to antiparkinson drugs. […] The diagnosis of PD during life is based upon its distinctive clinical features discerned from the history and neurologic examination. At a minimum, bradykinesia plus either tremor or rigidity must be present to consider the diagnosis of PD. In addition, an unequivocal, beneficial response to dopaminergic therapy is an important supportive feature of the diagnosis, while the absence of an observable response to high-dose levodopa therapy (>1000 mg daily) in patients with at least a moderate severity of parkinsonism makes the diagnosis of PD extremely unlikely. […] Postural instability is also a feature of PD but usually does not appear until later in the course of the disease. Thus, patients with parkinsonian signs who exhibit postural instability early in the course of the illness most likely have another form of parkinsonism.

• #29 The initial diagnosis and management of Parkinson’s disease

  https://www1.racgp.org.au/ajgp/2021/november/diagnosis-and-management-of-parkinsons

  Levodopa, in combination with carbidopa or benserazide, is the most effective therapy to control motor symptoms in patients with Parkinsons disease. […] There is no rationale to delaying levodopa therapy if there is anything more than mild disability, especially in older patients. […] Patients who do not respond to levodopa should be referred early to a neurologist for re-evaluation of the diagnosis. […] An effective initial approach should encompass prompt recognition of the core features of Parkinsons disease; clear explanation of the diagnosis and symptoms, allowing time for patient questions; and timely initiation of first-line therapy, complemented by effective, open communication between GP, patient and neurologist.

• #30 Parkinson’s disease – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/parkinsons-disease/diagnosis-treatment/drc-20376062

  Alpha-synuclein test. This test, also called an alpha-synuclein seed amplification assay, detects Parkinson’s disease before symptoms begin. Alpha-synuclein clumps are a hallmark sign of Parkinson’s disease. Healthcare professionals can test for this condition in the skin or spinal fluid. […] In a 2023 study, researchers tested the spinal fluid of more than 1,000 people to look for clumps of the protein alpha-synuclein. The test accurately identified people with Parkinson’s disease 87.7% of the time. The test also was highly sensitive for detecting people at risk of Parkinson’s disease. […] This study of the alpha-synuclein seed amplification assay was the largest so far. Some researchers say the study may be a breakthrough for Parkinson’s disease diagnosis, research and treatment trials. But larger studies are needed. […] There’s hope among researchers that in the future, the test could be done using blood samples rather than spinal fluid.

• #31 Ask the MD: A Skin Test for Parkinson’s | Parkinson’s Disease

  https://www.michaeljfox.org/news/ask-md-skin-test-parkinsons

  Editors note (March 21, 2024): This blog describes a skin test that detects the biology of Parkinsons and related diseases, and, as such, is a valuable research tool. On March 20, 2024, researchers published data on the skin test in The Journal of the American Medical Association’s (JAMA) Network. […] Their results indicate that a high proportion of people who are diagnosed with Parkinsons or related diseases have a positive skin test. Further research will help validate these findings and clarify the tests role and benefit in clinical care. […] The test tells whether, at the time its done, a person has abnormal alpha-synuclein in their skin. It can point, generally, toward or away from Parkinsons and other diseases of alpha-synuclein, like MSA or DLB. It cannot yet, on its own or in a person without symptoms, diagnose or predict a specific disease. Your doctor must interpret the results in the context of your symptoms and physical examination to confirm or rule out a suspected disease.

• #32 Parkinson’s Disease: What It Is, Causes, Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/8525-parkinsons-disease-an-overview

  One of these tests looks for misfolded alpha-synuclein proteins in cerebrospinal fluid, which is the fluid that surrounds your brain and spinal cord. This test involves a spinal tap (lumbar puncture), where a healthcare provider inserts a needle into your spinal canal to collect some cerebrospinal fluid for testing. […] Another possible test involves a biopsy of surface nerve tissue. A biopsy includes collecting a small sample of your skin, including the nerves in the skin. The samples come from a spot on your back and two spots on your leg. Analyzing the samples can help determine if your alpha-synuclein has a certain kind of malfunction that could increase the risk of developing Parkinsons disease.

• #33 Updates in Diagnostic Testing in Parkinson Disease

  https://practicalneurology.com/diseases-diagnoses/movement-disorders/updates-in-diagnostic-testing-in-parkinson-disease/32164/

  Sensitivity and specificity of DaTscan results vary depending on disease stage and certainty of the clinical diagnosis. […] DaTscan imaging may provide additional diagnostic clarity in several situations. […] The quality of DaTscan images may differ among imaging centers, and interpretation of imaging results may vary among radiologists. […] DaTscan imaging provides valuable insights into the neurochemical changes associated with PD, but its routine use in diagnosis remains controversial. […] Detection of SynP in cutaneous nerve fibers and CSF has been developed as a novel diagnostic biomarker for these synucleinopathies. […] Advanced immunohistofluorescence techniques have enabled SynP identification in cutaneous samples. […] In a recent study, the proportions of individuals with cutaneous SynP detected by skin biopsy were 92.7% with PD.

• #34 New Blood Test Detects a Key Indicator of Parkinson’s Disease | Duke Department of Neurology

  https://neurology.duke.edu/news/new-blood-test-detects-key-indicator-parkinsons-disease

  Researchers have developed a blood test that detects Parkinsons disease, potentially establishing a way to help diagnose the condition before nervous system damage worsens. […] Currently, Parkinsons disease is diagnosed largely based on clinical symptoms after significant neurological damage has already occurred, said senior author Laurie Sanders, PhD, an associate professor in Duke School of Medicines departments of Neurology and Pathology and member of the Duke Center for Neurodegeneration and Neurotherapeutics. […] A simple blood test would allow us to diagnose the disease earlier and start therapies sooner, Sanders said. Additionally, a clear-cut diagnosis would accurately identify patients who could participate in drug studies, leading to the development of better treatments and potentially even cures.

• #35 Parkinson’s: New blood test may predict disease years before symptoms

  https://www.medicalnewstoday.com/articles/new-blood-test-could-predict-parkinsons-diseaase-7-years-before-symptoms

  The development of a biomarker test for early detection of Parkinson’s disease is a potentially transformative advancement, said Dr. Daniel Truong. […] If successfully implemented, this test could lead to earlier and more effective interventions, ultimately improving the lives of millions of individuals at risk for or living with Parkinson’s disease. […] By determining eight proteins in the blood, we can identify potential Parkinson’s patients several years in advance. […] This means that drug therapies could potentially be given at an earlier stage, which could possibly slow down disease progression or even prevent it from occurring. […] We have not only developed a test but can diagnose the disease based on markers that are directly linked to processes such as inflammation and degradation of non-functional proteins.

• #36 Parkinson’s disease – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/parkinsons-disease/diagnosis-treatment/drc-20376062

  Alpha-synuclein test. This test, also called an alpha-synuclein seed amplification assay, detects Parkinson’s disease before symptoms begin. Alpha-synuclein clumps are a hallmark sign of Parkinson’s disease. Healthcare professionals can test for this condition in the skin or spinal fluid. […] In a 2023 study, researchers tested the spinal fluid of more than 1,000 people to look for clumps of the protein alpha-synuclein. The test accurately identified people with Parkinson’s disease 87.7% of the time. The test also was highly sensitive for detecting people at risk of Parkinson’s disease. […] This study of the alpha-synuclein seed amplification assay was the largest so far. Some researchers say the study may be a breakthrough for Parkinson’s disease diagnosis, research and treatment trials. But larger studies are needed. […] There’s hope among researchers that in the future, the test could be done using blood samples rather than spinal fluid.

• #37 Prodromal and Early Parkinson’s Disease Diagnosis

  https://practicalneurology.com/articles/2018-may/prodromal-and-early-parkinsons-disease-diagnosis

  Earlier diagnosis may lead to earlier and more effective treatments. Currently accepted diagnostic criteria require the presence of bradykinesia and at least 1 other motor sign, such as cogwheel rigidity or rest tremor; in this article, we refer to this as motor-PD. However, there is increasing recognition that neurodegeneration begins decades before the appearance of motor signs, often with the development of nonmotor symptoms such as hyposmia and sleep disturbances. The long latent phase of PD, termed prodromal-PD, represents an opportunity for early recognition of incipient PD. Such early recognition could allow not only better prognostic counseling but also initiation of possible neuroprotective therapies at a stage when therapies might be most effective. Thus, early detection and treatment of these prodromal symptoms is essential for high-quality care. The best-characterized symptoms of prodromal-PD include hyposmia, constipation, mood disorders, and REM sleep behavior disorder (RBD).

• #38 The initial diagnosis and management of Parkinson’s disease

  https://www1.racgp.org.au/ajgp/2021/november/diagnosis-and-management-of-parkinsons

  The ability to pivot and turn may be lost, and patients turn en bloc, using multiple steps to turn. […] Rapid eye movement sleep behaviour disorder (RBD) occurs in approximately one-third of patients with Parkinsons disease and can precede the onset of motor symptoms by more than a decade. […] Prodromal Parkinsons disease may be further suggested by the presence of constipation, which can predate motor manifestations by more than 10 years, and hyposmia. […] The GPs role is critical in a patients experience with Parkinsons disease, and communication is an essential part of this, particularly in the early days where uncertainty regarding the diagnosis may exist. […] Patient satisfaction with the explanation of Parkinsons disease at the time of diagnosis has been shown to have a lasting impact on health-related quality of life, even many years after the diagnosis has been made.

• #39 Prodromal and Early Parkinson’s Disease Diagnosis

  https://practicalneurology.com/articles/2018-may/prodromal-and-early-parkinsons-disease-diagnosis

  Prodromal-PD refers to the stage at which individuals do not fulfill diagnostic criteria for PD (ie, bradykinesia and at least 1 other motor sign) but do exhibit signs and symptoms that indicate a higher than average risk of developing motor symptoms and a diagnosis of PD in the future. […] A number of prodromal symptoms in patients with PD have been identified. Of these, RBD appears to have the highest positive predictive value, whereas hyposmia, constipation, and mood disorders are relatively sensitive but nonspecific when considered in isolation. However, in a report from the population-based Honolulu-Asia aging study, the combination of more than 2 prodromal symptoms predicted a 4 times higher incidence of PD than a single prodromal feature. […] Given the mixed sensitivity and specificity of any 1 diagnostic tool for PD, effective screening algorithms must be multimodal. Most algorithms use a combination of prodromal symptoms and imaging or biochemical biomarkers to identify individuals at high risk of developing motor-PD. The goal of these and other multimodal screening tools is to identify a population at significant risk of PD both to improve counseling for individual patients as well as to identify a potential population for clinical trials of disease-modifying agents at a stage where intervention is likely to be most effective. Thus, early recognition and diagnosis is crucial to the future of PD management.

• #40 Update on the diagnosis and management of Parkinson’s disease

  https://pmc.ncbi.nlm.nih.gov/articles/PMC7385761/

  Parkinson’s disease (PD) is diagnosed where bradykinesia occurs together with rigidity or tremor, in the presence of supporting features. The diagnosis is clinical, and attention should be paid to exclusion criteria indicating an alternative diagnosis and to red flag features. […] The diagnosis of PD is clinical and requires bradykinesia, defined as slowness of movement and decrement in amplitude or speed, usually assessed using finger tapping, foot tapping or pronationsupination hand movements. In addition, rest tremor or rigidity is required to confirm a parkinsonian syndrome. […] Post-mortem studies of clinically diagnosed PD show an overall diagnostic accuracy of 81%, indicating the need to re-appraise the clinical diagnosis regularly. […] The most common causes of PD misdiagnosis are atypical parkinsonian syndromes, including multiple system atrophy (MSA) and progressive supranuclear palsy (PSP). […] The diagnosis of PD remains clinical, and close attention and review for features indicating an alternative diagnosis is key given the absence of a definitive diagnostic test.

• #41 Parkinson’s disease: clinical features and diagnosis | Journal of Neurology, Neurosurgery & Psychiatry

  https://jnnp.bmj.com/content/79/4/368

  PD is diagnosed on clinical criteria; there is no definitive test for diagnosis. Historically, pathological confirmation of the hallmark Lewy body on autopsy has been considered the criterion standard for diagnosis. In clinical practice, diagnosis is typically based on the presence of a combination of cardinal motor features, associated and exclusionary symptoms, and response to levodopa. […] Diagnostic criteria have been developed by the UK Parkinsons Disease Society Brain Bank and the National Institute of Neurological Disorders and Stroke. […] Misdiagnosis of PD can arise for a number of reasons. In a community based study of patients taking antiparkinsonian medication, the most common causes of misdiagnoses were essential tremor, Alzheimers disease and vascular parkinsonism. More than 25% of patients in this study did not respond to antiparkinsonian medication.

• #42 Parkinson’s disease: clinical features and diagnosis | Journal of Neurology, Neurosurgery & Psychiatry

  https://jnnp.bmj.com/content/79/4/368

  PD is diagnosed on clinical criteria; there is no definitive test for diagnosis. Historically, pathological confirmation of the hallmark Lewy body on autopsy has been considered the criterion standard for diagnosis. In clinical practice, diagnosis is typically based on the presence of a combination of cardinal motor features, associated and exclusionary symptoms, and response to levodopa. […] Diagnostic criteria have been developed by the UK Parkinsons Disease Society Brain Bank and the National Institute of Neurological Disorders and Stroke. […] Misdiagnosis of PD can arise for a number of reasons. In a community based study of patients taking antiparkinsonian medication, the most common causes of misdiagnoses were essential tremor, Alzheimers disease and vascular parkinsonism. More than 25% of patients in this study did not respond to antiparkinsonian medication.

• #43 Parkinson’s disease – Wikipedia

  https://en.wikipedia.org/wiki/Parkinson%27s_disease

  Diagnosis is primarily based on signs and symptoms, typically motor-related, identified through neurological examination. […] Diagnosis in later stages requires the manifestation of parkinsonism, specifically bradykinesia and rigidity or tremor. […] A PD diagnosis is typically confirmed by two of the following criteria: responsiveness to levodopa, resting tremor, levodopa-induced dyskinesia, or with dopamine transporter single-proton emission computed tomography. […] Diagnosis can be aided by molecular imaging techniques such as magnetic resonance imaging (MRI), positron emission tomography (PET), and single-photon emission computed tomography (SPECT). […] Although early stage diagnosis is not reliable, prodromal diagnosis may consider previous family history of Parkinson’s and possible early symptoms like rapid eye movement sleep behavior disorder (RBD), reduced sense of smell, and gastrointestinal issues. […] Definitive diagnoses can only be made post-mortem through pathological analysis. […] Misdiagnosis is common, with a reported error rate of near 25 percent, and diagnoses often change during follow-ups.

• #44 Parkinson Disease | AAFP

  https://www.aafp.org/pubs/afp/issues/2020/1201/p679.html

  Features supporting a diagnosis of Parkinson disease are asymmetric clinical motor presentation, gradual onset, and bradykinesia. […] Motor symptom response to levodopa also supports the diagnosis. […] Insidious progression of symptoms and postural instability are hallmarks of later stages of Parkinson disease. […] Factors indicating another diagnosis are rapid disease progression, early or symmetric bilateral body involvement, and inadequate response to levodopa. […] Although upper extremity tremor is the more common presenting symptom in Parkinson disease, the development of lower extremity tremor favors a diagnosis of Parkinson disease over essential tremor.

• #45 Parkinson Disease | AAFP

  https://www.aafp.org/pubs/afp/issues/2020/1201/p679.html

  Features supporting a diagnosis of Parkinson disease are asymmetric clinical motor presentation, gradual onset, and bradykinesia. […] Motor symptom response to levodopa also supports the diagnosis. […] Insidious progression of symptoms and postural instability are hallmarks of later stages of Parkinson disease. […] Factors indicating another diagnosis are rapid disease progression, early or symmetric bilateral body involvement, and inadequate response to levodopa. […] Although upper extremity tremor is the more common presenting symptom in Parkinson disease, the development of lower extremity tremor favors a diagnosis of Parkinson disease over essential tremor.

• #46 Getting Diagnosed | Parkinson’s Foundation

  https://www.parkinson.org/understanding-parkinsons/getting-diagnosed

  Finding out you have Parkinson’s can be a lengthy process. Explore how a Parkinson’s diagnosis is made and what type of diagnostic tools are used. […] Parkinsons disease (PD) is a clinical diagnosis. This means that an individuals history, symptoms, and physical exam are used to make the diagnosis. There is not a specific lab or imaging test that can diagnose PD. However, certain tests such as magnetic resonance imaging of the brain (MRI brain), a dopamine transporter scan (DaT scan), or blood work can be used to support the diagnosis of PD or to rule out other medical conditions that can mimic PD. […] Making an accurate diagnosis of Parkinsons, particularly in its early stages, can be difficult. Often, an internist or family physician is the first to make a diagnosis. Many people may seek an additional opinion from a movement disorder specialist. A movement disorder specialist is a neurologist with experience and specific training in the assessment and treatment of PD and related disorders.

• #47 Diagnosing Parkinson’s Disease | APDA

  https://www.apdaparkinson.org/what-is-parkinsons/diagnosing/

  Only a general neurologist or movement disorder specialist can tell you with reasonable certainty if you have Parkinsons. If for some reason you are not comfortable with the results your first physician provided, getting a second opinion from another general neurologist or movement disorder specialist is always an option, and is a common practice. It is important to feel comfortable with and confident in your physician to ensure the best possible outcome for you.

• #48 Diagnosing Parkinson’s Disease | APDA

  https://www.apdaparkinson.org/what-is-parkinsons/diagnosing/

  Only a general neurologist or movement disorder specialist can tell you with reasonable certainty if you have Parkinsons. If for some reason you are not comfortable with the results your first physician provided, getting a second opinion from another general neurologist or movement disorder specialist is always an option, and is a common practice. It is important to feel comfortable with and confident in your physician to ensure the best possible outcome for you.

• #49 How Parkinson’s Disease Is Diagnosed | APDA | American Parkinson Disease Association

  https://www.apdaparkinson.org/how-parkinsons-disease-is-diagnosed/

  A physician looks for the presence or absence of the possible symptoms of Parkinsons disease by interviewing the patient and performing a detailed neurologic examination. […] While there is presently no definitive test for Parkinsons, it can often be identified by a general neurologist, who is trained to diagnose and treat neurologic disorders. […] To avoid misdiagnosis, consultation with a movement disorder specialist (MDS) is recommended. […] Typically, a trained physician will only consider the diagnosis of Parkinsons disease if the person being examined has at least two of the core motor symptoms of Parkinsons, including tremor, the characteristic bradykinesia (slowness of movement), or rigidity. […] At the end of your visit, the physician should discuss with you why you may or may not have Parkinsons disease and the level of certainty about the diagnosis.

• #50 Prodromal and Early Parkinson’s Disease Diagnosis

  https://practicalneurology.com/articles/2018-may/prodromal-and-early-parkinsons-disease-diagnosis

  Prodromal-PD refers to the stage at which individuals do not fulfill diagnostic criteria for PD (ie, bradykinesia and at least 1 other motor sign) but do exhibit signs and symptoms that indicate a higher than average risk of developing motor symptoms and a diagnosis of PD in the future. […] A number of prodromal symptoms in patients with PD have been identified. Of these, RBD appears to have the highest positive predictive value, whereas hyposmia, constipation, and mood disorders are relatively sensitive but nonspecific when considered in isolation. However, in a report from the population-based Honolulu-Asia aging study, the combination of more than 2 prodromal symptoms predicted a 4 times higher incidence of PD than a single prodromal feature. […] Given the mixed sensitivity and specificity of any 1 diagnostic tool for PD, effective screening algorithms must be multimodal. Most algorithms use a combination of prodromal symptoms and imaging or biochemical biomarkers to identify individuals at high risk of developing motor-PD. The goal of these and other multimodal screening tools is to identify a population at significant risk of PD both to improve counseling for individual patients as well as to identify a potential population for clinical trials of disease-modifying agents at a stage where intervention is likely to be most effective. Thus, early recognition and diagnosis is crucial to the future of PD management.

• #51 New Blood Test Detects a Key Indicator of Parkinson’s Disease | Duke Department of Neurology

  https://neurology.duke.edu/news/new-blood-test-detects-key-indicator-parkinsons-disease

  Researchers have developed a blood test that detects Parkinsons disease, potentially establishing a way to help diagnose the condition before nervous system damage worsens. […] Currently, Parkinsons disease is diagnosed largely based on clinical symptoms after significant neurological damage has already occurred, said senior author Laurie Sanders, PhD, an associate professor in Duke School of Medicines departments of Neurology and Pathology and member of the Duke Center for Neurodegeneration and Neurotherapeutics. […] A simple blood test would allow us to diagnose the disease earlier and start therapies sooner, Sanders said. Additionally, a clear-cut diagnosis would accurately identify patients who could participate in drug studies, leading to the development of better treatments and potentially even cures.

• #52 The initial diagnosis and management of Parkinson’s disease

  https://www1.racgp.org.au/ajgp/2021/november/diagnosis-and-management-of-parkinsons

  The ability to pivot and turn may be lost, and patients turn en bloc, using multiple steps to turn. […] Rapid eye movement sleep behaviour disorder (RBD) occurs in approximately one-third of patients with Parkinsons disease and can precede the onset of motor symptoms by more than a decade. […] Prodromal Parkinsons disease may be further suggested by the presence of constipation, which can predate motor manifestations by more than 10 years, and hyposmia. […] The GPs role is critical in a patients experience with Parkinsons disease, and communication is an essential part of this, particularly in the early days where uncertainty regarding the diagnosis may exist. […] Patient satisfaction with the explanation of Parkinsons disease at the time of diagnosis has been shown to have a lasting impact on health-related quality of life, even many years after the diagnosis has been made.

• #53 Update on the diagnosis and management of Parkinson’s disease

  https://pmc.ncbi.nlm.nih.gov/articles/PMC7385761/

  Parkinson’s disease (PD) is diagnosed where bradykinesia occurs together with rigidity or tremor, in the presence of supporting features. The diagnosis is clinical, and attention should be paid to exclusion criteria indicating an alternative diagnosis and to red flag features. […] The diagnosis of PD is clinical and requires bradykinesia, defined as slowness of movement and decrement in amplitude or speed, usually assessed using finger tapping, foot tapping or pronationsupination hand movements. In addition, rest tremor or rigidity is required to confirm a parkinsonian syndrome. […] Post-mortem studies of clinically diagnosed PD show an overall diagnostic accuracy of 81%, indicating the need to re-appraise the clinical diagnosis regularly. […] The most common causes of PD misdiagnosis are atypical parkinsonian syndromes, including multiple system atrophy (MSA) and progressive supranuclear palsy (PSP). […] The diagnosis of PD remains clinical, and close attention and review for features indicating an alternative diagnosis is key given the absence of a definitive diagnostic test.

• #54 Parkinson’s 101 | Parkinson’s Disease

  https://www.michaeljfox.org/parkinsons-101

  Doctors use your medical history and physical examination to diagnose Parkinson’s disease (PD). No blood test, brain scan or other test can be used to make a definitive diagnosis of PD. […] Doctors diagnose Parkinsons „clinically” the diagnosis is based on a persons medical history, answers to certain questions and a physical examination. […] If you suspect you have Parkinson’s, you should see a movement disorder specialist, who is a neurologist with specialized training in Parkinsons and other movement disorders. […] A biomarker test is now available to diagnose Parkinsons objectively, based on the presence of a misfolded protein called alpha-synuclein. Called the alpha-synuclein seeding amplification assay, the test can detect the misfolded protein in spinal fluid in people who show clinical symptoms of the disease and also in people who have not yet shown symptoms but are at a high risk of developing PD.

• #55 Getting Diagnosed | Parkinson’s Foundation

  https://www.parkinson.org/understanding-parkinsons/getting-diagnosed

  The newest criteria for diagnosing Parkinsons was developed by the International Parkinson and Movement Disorder Society (MDS), and reflect the most current understanding of PD. […] To consider a diagnosis of Parkinsons disease, a person must have bradykinesia (slowness of movement). In addition to bradykinesia, a person must also have one or more of the following: Shaking or tremor in a limb that occurs while it is at rest, Stiffness or rigidity of the arms, legs, or trunk, Trouble with balance and falls. […] The first and most important diagnostic tool for Parkinsons is a medical history and physical examination conducted by a neurologist. […] A neurologist will make a diagnosis based on: A detailed history of symptoms, existing medical conditions, current and past medications, family history, and lifestyle factors. Certain medical conditions, as well as some medications, can cause symptoms similar to Parkinsons.

• #56 Parkinson’s disease – Symptoms and causes – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/parkinsons-disease/symptoms-causes/syc-20376055

  See a healthcare professional if you have any symptoms of Parkinson’s disease. This will help diagnose your condition and rule out other causes. […] In Parkinson’s disease, nerve cells in the brain called neurons slowly break down or die. Many Parkinson’s disease symptoms are caused by a loss of neurons that produce a chemical messenger in the brain. This messenger is called dopamine. […] The cause of Parkinson’s disease is unknown, but several factors seem to play a role, including: […] Diagnosis and differential diagnosis of Parkinson disease. […] Diagnosis treatment.

• #57 Ask the MD: A Skin Test for Parkinson’s | Parkinson’s Disease

  https://www.michaeljfox.org/news/ask-md-skin-test-parkinsons

  The diagnosis of PD remains clinical not based on a test, but on your medical history and an expert doctors examination. Only when a person has the cardinal motor symptoms of Parkinsons slowness plus tremor or stiffness can a diagnosis be made. The test doesnt change that yet. But soon, the skin test, like -syn SAA in CSF and others in the pipeline, will, hopefully, transform how and when doctors can diagnose and care for disease. […] These tests should lead to better understanding of the disease and, ultimately, toward more personalized treatment. […] The bottom line: Like -syn SAA in CSF, this is a promising development in the field. It has immediate and broad implications for research and more efficient clinical trial testing. And it will likely have widespread effects on diagnosis, care and prognosis of Parkinsons and related disease in the future.

• #58 Updates in Diagnostic Testing in Parkinson Disease

  https://practicalneurology.com/diseases-diagnoses/movement-disorders/updates-in-diagnostic-testing-in-parkinson-disease/32164/

  CSF -Synuclein Testing by Seed Amplification Assay enables its detection by seed amplification assays (SAAs). […] Coupled with a thorough clinical evaluation, Syn tests aid in the differentiation of synucleinopathies (PD and MSA) from other proteinopathies. […] Genetic testing options are expanding, with clinical, research, and direct-to-consumer avenues becoming increasingly available. […] The diagnosis of a genetic form of PD does not alter symptomatic management. […] Since the associated genes for several familial forms of PD remain unidentified, a negative genetic test result does not definitively exclude a genetic basis for PD. […] From Syn detection in biosamples to multigene panels, the diagnostic arsenal in PD continues to expand.

• #59 Early diagnosis of Parkinson\’s | PortalCLÍNIC

  https://www.clinicbarcelona.org/en/news/can-parkinsons-be-detected-years-before-the-first-symptoms-appear

  SPECT imaging has been used for years. It is popularly known as the Parkinson’s test, but technically it is not considered a specific diagnostic test, since it can be found altered in any neurodegenerative type parkinsonism. […] However, an altered dopamine transporter SPECT image in the presence of few or a single prodromal Parkinson’s symptom is associated with a greater risk of imminent progression towards the full form of this disease. […] In 2016, two independent research groups demonstrated that aggregation of the protein alpha-synuclein can be detected in the cerebrospinal fluid of patients with Parkinson’s and those at risk of having it. […] The difference between these two tests (SPECT and Syn RT-QuIC) is found in the fact that although SPECT can detect incipient alterations in people who only have prodromal symptoms, it implies that there is already a degeneration of the dopaminergic neurons; while RT-QulC is capable of detecting alpha-synuclein alteration, even before neuron degeneration – that is, earlier in cases where the dopaminergic neurons has not yet been altered. […] In short, it seems that the combination of prodromal symptoms and biomarkers such as SPECT and RT-QulC could allow early detection that would theoretically benefit future neuroprotective treatments more than cases diagnosed later with traditional clinical criteria.

Zobacz więcej